Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-09-26
2006-09-26
Jiang, S. Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S027610, C536S027630, C536S027700
Reexamination Certificate
active
07112574
ABSTRACT:
Novel C2,8-disubstituted adenosine derivatives disclosed herein have been found to be potent adenosine receptor agonists, in particular for the A2A receptor. The said compounds have biological activity against conditions such as hypertension, ischemic heart disease, ischemic brain disease, psychosis and wound healing. Further, the invention also discloses a process for the preparation of such compounds and pharmaceutical compositions comprising them.
REFERENCES:
patent: 3968102 (1976-07-01), Suehiro et al.
patent: 5189027 (1993-02-01), Miyashita et al.
patent: 5278150 (1994-01-01), Olsson et al.
patent: 5877180 (1999-03-01), Linden et al.
patent: 5998423 (1999-12-01), Manneth et al.
patent: 6407076 (2002-06-01), Box et al.
patent: 6448235 (2002-09-01), Linden et al.
patent: 6514949 (2003-02-01), Linden et al.
patent: 6576620 (2003-06-01), Belardinelli et al.
patent: 6605597 (2003-08-01), Zablocki et al.
patent: WO 00/72799 (2000-12-01), None
patent: WO00/72799 (2000-12-01), None
patent: WO 00/78777 (2000-12-01), None
(V) Niedzwicki et al., “Structure-Activity Relationship of Ligands of Human Plasma Adenosine Deaminase2,” Biochemical Pharmacology, 41(11), 1615-1624 (Jun. 1, 1991).
(W) Zady et al., “Kinetics and Mechanism of Carbon-8 Methylation of Purine Bases and Nucleosides by Methyl Radicals,” Journal American Chemical Society, 99(15), 5096-5101 (Jul. 20, 1977).
(X) Fujita et al., “Antiviral Activity of 2-Aminoadenosine, 2-Aminodeoxyadenosine and Their N6-Substituted Derivatives in Vero Cells,” Oyo Yakuri, 49(6), 627-634 (1995).
(R)van Tilburg et al., “N6,5′-Disubstituted Adenosine Derivatives as Partial Agonists for the Humans Adenosine A3 Receptor,” Journal of Medicinal Chemistry, 42(8), 1393-1400 (1999); Web published Mar. 31, 1999.
(S) Kanaya et al., “Poly(2-amino-8-methyldeoxyadenylic acid): Contrasting Effects in Deoxy- and Ribopolynucleotides of 2-Amino and 8-Methyl Substituents,” Biochemistry, 26(22), 7159-7165 (1987).
(T) Marumoto et al., “A New Method for Synthesis of Nucleoside 3′,5′-Cyclic Phosphates. Cyclization of Nucleoside 5′-Trichloromethylphosphonates,” □□Chemical & Pharmaceutical Bulletin, 23(10), 2295-2300 (Oct. 1975).
(U) Ikehara et al., “Studies of Nucleosides and Nucleotides. LXXXI. Synthesis and Characterization of 8-Methyladenosine,” □□Chemical & Pharmaceutical Bulletin, 25(10), 2702-2707 (Oct. 1977).
(V) Niedzwicki et al., “Structure-Activity Relationship of Ligands of Human Plasma Adenosine Deaminase2,” Biochemical Pharmacology, 41(11), 1615-1624 (Jun. 1, 1991).
(W) Zady et al., “Kinetics and Mechanism of Carbon-8 Methylation of Purine Bases and Nucleosides by Methyl Radicals,” Journal American Chemical Society, 99(15), 5096-5101 (Jul. 20, 1977).
(X) Fujita et al., “Antiviral Activity of 2-Aminoadenosine, 2-Aminodeoxyadenosine and Their N6-Substituted Derivatives in Vero Cells,” Oyo Yakuri, 49(6), 627-634 (1995).
van Tilburg et al., “N6,5′-Disubstituted Adenosine Derivatives as Partial Agonists for the Humans Adenosine A3Receptor,”Journal of Medicinal Chemistry, 42(8), 1393-1400 (1999); Web published Mar. 31, 1999.
Kanaya et al., “Poly(2-amino-8-methyldeoxyadenylic acid): Contrasting Effects in Deoxy- and Ribopolynucleotides of 2-Amino and 8-Methyl Substituents,”Biochemistry, 26(22), 7159-7165 (1987).
Marumoto et al., “A New Method for Synthesis of Nucleoside 3′,5′-Cyclic Phosphates. Cyclization of Nucleoside 5′-Trichloromethylphosphonates,”Chemical&Pharmaceutical Bulletin, 23(10), 2295-2300 (Oct. 1975).
Ikehara et al., “Studies of Nucleosides and Nucleotides. LXXXI. Synthesis and Characterization of 8-Methyladenosine,”Chemical&Pharmaceutical Bulletin, 25(10), 2702-2707 (Oct. 1977).
Niedzwicki et al., “Structure-Activity Relationship of Ligands of Human Plasma Adenosine Deaminase2,”Biochemical Pharmacology, 41(11), 1615-1624 (Jun. 1, 1991).
Zady et al., “Kinetics and Mechanism of Carbon-8 Methylation of Purine Bases and Nucleosides by Methyl Radicals,”Journal American Chemical Society, 99(15), 5096-5101 (Jul. 20, 1977).
Fujita et al., “Antiviral Activity of 2-Aminoadenosine, 2-Aminodeoxyadenosine and Their N6-Substituted Derivatives in Vero Cells,”Oyo Yakuri, 49(6), 627-634 (1995).
Chemical Abstract No. 84:17662 & Marumoto et al., Chem.Pharm.Bull., (1975), 23(10), 2295-2300. See abstract and compound with registry No. 57627-54-0, (Chem. Abstr., 1976).
Chemical Abstract No. 87: 136271 & Zady et al, J. Am. Chem. Soc., (1977), 99(15), 5096-5101. See abstract and compound with registry No. 63954-66-5, (Chem. Abstr., 1977).
Chemical Abstract No. 88: 121631 & Ikehara et al., Chem. Pharm. Bull. (1977), 25(10), 2702-2707. See abstract and compound with registry No. 65991-09-5, (Chem. Abstr, 1978).
Chemical Abstract No. 107: 193251 & Kanaya et al., Biochemistry. (1987), 26(22), 7159-7165. See abstract and compound with registry No. 80326-50-7, (Chem. Abstr., 1987).
Chemical Abstract No. 114: 207670 & Ratsep et al., Nucleosides & Nucleotides, (1990), 9(8), 1001-1013. See abstract and compound with registry No. 133502-38-2, (Chem. Abstr., 1991).
Chemical Abstract No. 115: 67360 & Niedzwicki et al., Biochem. Pharmacol, (1991), 41(11), 1615-1624. See abstract and compound with registry No. 7502-60-7, (Chem. Abstr., 1991).
Chemical Abstract No. 123: 47455 & Fujita et al., Oyo Yakuri, (1995), 49(6), pp. 627-634. See abstract, (Chem. Abstr., 1995).
Camaioni, et al., “Adenosine Receptor Agonists: Synthesis and Biological Evaluation of the Diastereoisomers of 2-(3-Hydroxy-3-phenyl-1-propyn-1-yl)NECA”, Bioorganic & Medicinal Chemistry. 1997, vol. 5 No. 12, 2267- 2275.
Cristalli, et al., “2-Alkynyl Derivatives of Adenosine and Adenosine-5′-N-ethyluronamide as Selective Agonists at A2Adenosine Receptors”, J. Med. Chem. 1992, vol. 35, 2363-2368, (Issue No. 13).
Francis, et al., “Highly Selective Adenosine A2Receptor Agonists in a Series of N-Alkylated 2-Aminoadenosines”, J. Med Chem. 1991, vol. 34, 2570-2579, (Issue No. 8).
Homma, et al., “Nucleosides and Nucleotides. 112. 2-(1-Hexyn-1-yl)adenosine-5′-uroamides: A New Entry of Selective A2Adenosine Receptor Agoinists with Potent Antigypertensive Activity,” J. Med. Chem. 1992, vol. 35, 2881-2890, (Issue No. 15).
Klotz, et al., “2-Substituted N-ethylcarboxamidoadenosine Derivatives as High-affinity Agonists at Human A3Adenosine Receptors”, Naunyn-Schmiedeberg's Arch Pharmacol. 1999, vol. 360, 103-108.
Matsuda, et a:., “Palladium-catalyzed Cross-Coupling of 2-lodoadenosine with Terminal Alkynes: Synthesis and Biological Activities of 2-Alkynyladenosines”, Chem. Pharm. Bull. 1985, vol. 33(4), 1766-1769.
Matsuda, et al., “Nucleosides and Nucleotides. 103. 2-Alkynyladenosines: A Novel Class of Selective Adenosine A2Receptor Agonists with Potent Antihypertensive Effects”, J. Med. Chem. 1992, vol. 35, 241-252, (Issue No. 2; Jan. 24, 1992).
Ratsep, et al., “8-Diazoguanosine, 2,8-Diaminoadenosine and Other Purine Nucleosides Derived from Guanosine”, Nucleosides & Nucleotides. 1990, vol. 9 (8), 1001-1013.
Roelen, et al., “N6, C8-Disubstituted Adenosine Derivatives as Partial Agonists for Adenosine A1Receptors”, J. Med. Chem. 1996, vol. 39, 1463-1471, (Issue No. 7; Mar. 29, 1996).
Vittori, et a;., “2-Alkenyl and 2-Alkyl Derivatives of Adenosine and Adenosine-5′-N-Ethyluronamide: Different Affinity and Selectivity of E-and Z-Diastereomers at A2AAdenosine Receptors”, J. Med. Chem. 1996, vol. 39, 4211-4217, (Issue No. 21).
Vittori, et al., “Synthesis and Receptor Affinity of Polysubstituted Adenosines”, Nucleosides & Nucleotides. 1999, vol. 18(4&5), 739-740.
Volpini,
Ijzerman Ad
Van Tilburg Erica
Browdy and Neimark PLLC
Can-Fite Biopharma Ltd.
Crane L. E.
Jiang S. Anna
Universiteit Leiden
LandOfFree
C2,8-disubstituted adenosine derivatives and their different... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with C2,8-disubstituted adenosine derivatives and their different..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C2,8-disubstituted adenosine derivatives and their different... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3556016